DocuSign director Wilderotter sells $68,800 in stock

Mary Agnes Wilderotter, a director at DocuSign, Inc., sold 1,000 shares of the company's common stock on October 1, 2026. The shares were sold at $68.8 each, amounting to a total of $68,800. This transaction was executed under a pre-existing Rule 10b5-1 plan adopted by Ms. Wilderotter. After this sale, she directly holds 2,199 shares of DocuSign common stock.

The stock has risen 43% over the past six months, currently trading at $69.01 with a market capitalization of $13 billion. Despite this insider sale, the stock appears undervalued, suggesting it may be an attractive option for investors seeking undervalued stocks. For a more detailed analysis of DocuSign's valuation and financial health, investors can refer to the Pro Research Report.

Recently, Docusign reported a revenue growth of 9.4% in Q2, boosted by digital sales and Identity and Access Management (IAM) bookings. This growth has led to adjustments in price targets by several financial firms, with Citi and Baird raising their targets to $72, Morgan Stanley to $75, and Needham maintaining a Hold rating. However, Wells Fargo adjusted its target to $60, citing the company's IAM growth and revenue performance.